Showing 131 - 140 of 3,985
We exploit a controlled frameless laboratory experiment to study settlement negotiations and the plaintiff's decision to raise a lawsuit in case of an impasse. We find that greater variance in court outcomes increases the litigation rate and lowers the settlement rate. This latter finding goes...
Persistent link: https://www.econbiz.de/10010281632
Persistent link: https://www.econbiz.de/10010289019
We utilize case-level data from a large Belgian court to study a policy-relevant but thus far empirically unexplored aspect of judicial behavior: the time that a judge takes to deliberate on a case before rendering a verdict. Exploiting the de facto random administrative assignment of filed...
Persistent link: https://www.econbiz.de/10011522447
We study the optimal design of alternative dispute resolution (ADR) mechanisms by a third-party mediator. ADR takes place before two litigants face each other in court. Litigation is a legal contest with players who are privately informed about the cost of collecting admissible evidence. Players...
Persistent link: https://www.econbiz.de/10011527813
The contributory infringement rule assesses liability to a third party that contributes tothe infringement of a patent. Not only are firms that directly infringe liable, those whoindirectly contribute are also liable. We investigate how this rule affects the creation of anetwork of members...
Persistent link: https://www.econbiz.de/10009360891
Given the urgent need to dramatically reduce greenhouse gas emissions, and concern regarding insufficient climate action and ambition across the globe, NGOs and individuals are increasingly turning to the courts to force States, public authorities, and private entities to increase their climate...
Persistent link: https://www.econbiz.de/10014374242
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...
Persistent link: https://www.econbiz.de/10012141882
This paper describes and analyzes the occurrence and extent of oppositions initiated against plant biotechnology patents granted by the European Patent Office (EPO). The opposition mechanism is a legal procedure that allows any third party to challenge the validity of patents awarded by the EPO....
Persistent link: https://www.econbiz.de/10012142367
Effective civil judicial remedies are often inaccessible to victims of transnational corporations (TNCs) from economically developed states that operate in developing or emerging states. The general consensus is that local capacity development is the most practical solution. The alternative...
Persistent link: https://www.econbiz.de/10012142988
What is the impact of caseload on judicial decision-making? Is increasing judicial staff effective in improving judicial services? To address these questions, we exploit a natural, near-randomized experiment in the Israeli judiciary. In 2012, six senior registrars were appointed in two of the...
Persistent link: https://www.econbiz.de/10012428598